{"entity":{"type":"insider","cik":"0001324991","url":"/insider/0001324991","json_url":"/insider/0001324991.json","name":"Tyree James L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":115,"n_filings":29,"first":"2006-02-22","last":"2024-12-30","span_basis":"filed_date"},"name_variants":[{"name":"Tyree James L","source":"filing","n_filings":29,"first_seen":"2006-02-22","last_seen":"2024-12-30"}],"transactions":[{"id":2712710,"accession":"0001415889-24-030248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-030248","line_url":"/filing/0001415889-24-030248#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3460.0,"shares_display":"3,460","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":8511.6,"total_display":"8,511.60","total_whole":"8,512","shares_owned_after":45791.0,"shares_owned_after_display":"45,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2024-12-30","scope":"insider"},{"id":2070605,"accession":"0001415889-24-023335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023335","line_url":"/filing/0001415889-24-023335#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1730.0,"shares_display":"1,730","price_per_share":2.6005,"price_display":"2.60","price_state":"stated","total_value":4498.865,"total_display":"4,498.86","total_whole":"4,499","shares_owned_after":47521.0,"shares_owned_after_display":"47,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-12","scope":"insider"},{"id":2330084,"accession":"0001415889-24-016110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-016110","line_url":"/filing/0001415889-24-016110#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":9710.0,"shares_owned_after_display":"9,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-06-07","scope":"insider"},{"id":2529089,"accession":"0001104659-24-035117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-035117","line_url":"/filing/0001104659-24-035117#line-1","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10251.0,"shares_display":"10,251","price_per_share":1.1182,"price_display":"1.12","price_state":"stated","total_value":11462.6682,"total_display":"11,462.67","total_whole":"11,463","shares_owned_after":188251.0,"shares_owned_after_display":"188,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":7837174,"accession":"0001209191-23-058710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058710","line_url":"/filing/0001209191-23-058710","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":13.218779488888888,"price_display":"13.22","price_state":"stated","total_value":118969.0154,"total_display":"118,969.02","total_whole":"118,969","shares_owned_after":6807.0,"shares_owned_after_display":"6,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider","n_lines":2},{"id":8738692,"accession":"0001808665-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808665-23-000020","line_url":"/filing/0001808665-23-000020#line-1","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43143.0,"shares_display":"43,143","price_per_share":5.9979,"price_display":"6.00","price_state":"stated","total_value":258767.3997,"total_display":"258,767.40","total_whole":"258,767","shares_owned_after":167308.0,"shares_owned_after_display":"167,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-05","filed_date":"2023-05-05","scope":"insider"},{"id":6149221,"accession":"0001209191-22-044891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044891","line_url":"/filing/0001209191-22-044891#line-1","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.22,"price_display":"50.22","price_state":"stated","total_value":502200.0,"total_display":"502,200.00","total_whole":"502,200","shares_owned_after":9138.0,"shares_owned_after_display":"9,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-08","scope":"insider"},{"id":6251663,"accession":"0001209191-22-036438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-036438","line_url":"/filing/0001209191-22-036438","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3863.0,"shares_display":"3,863","price_per_share":25.661265959099147,"price_display":"25.66","price_state":"stated","total_value":99129.4704,"total_display":"99,129.47","total_whole":"99,129","shares_owned_after":19197.0,"shares_owned_after_display":"19,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider","n_lines":2},{"id":6689352,"accession":"0001808665-22-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808665-22-000039","line_url":"/filing/0001808665-22-000039#line-1","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44643.0,"shares_display":"44,643","price_per_share":2.3558,"price_display":"2.36","price_state":"stated","total_value":105169.9794,"total_display":"105,169.98","total_whole":"105,170","shares_owned_after":210451.0,"shares_owned_after_display":"210,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":4958802,"accession":"0001209191-21-070839","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-070839","line_url":"/filing/0001209191-21-070839","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37500.0,"shares_display":"37,500","price_per_share":35.017725381333335,"price_display":"35.02","price_state":"stated","total_value":1313164.7018,"total_display":"1,313,164.70","total_whole":"1,313,165","shares_owned_after":15275.0,"shares_owned_after_display":"15,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider","n_lines":3},{"id":4785281,"accession":"0001209191-21-035562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-035562","line_url":"/filing/0001209191-21-035562#line-2","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2454.0,"shares_display":"2,454","price_per_share":9.762,"price_display":"9.76","price_state":"stated","total_value":23955.948,"total_display":"23,955.95","total_whole":"23,956","shares_owned_after":15275.0,"shares_owned_after_display":"15,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-24","scope":"insider"},{"id":3013435,"accession":"0001209191-20-003510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-003510","line_url":"/filing/0001209191-20-003510","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":37.05621075,"price_display":"37.06","price_state":"stated","total_value":1111686.3225,"total_display":"1,111,686.32","total_whole":"1,111,686","shares_owned_after":20060.0,"shares_owned_after_display":"20,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-01-15","scope":"insider","n_lines":2},{"id":2699597,"accession":"0001209191-16-123070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-123070","line_url":"/filing/0001209191-16-123070#line-2","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5544.0,"shares_display":"5,544","price_per_share":4.3898,"price_display":"4.39","price_state":"stated","total_value":24337.0512,"total_display":"24,337.05","total_whole":"24,337","shares_owned_after":20575.0,"shares_owned_after_display":"20,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":2498565,"accession":"0001179110-16-025263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-025263","line_url":"/filing/0001179110-16-025263#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"Innoviva, Inc.","issuer_ticker":"INVA","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":813.0,"shares_display":"813","price_per_share":10.47,"price_display":"10.47","price_state":"stated","total_value":8512.11,"total_display":"8,512.11","total_whole":"8,512","shares_owned_after":50697.0,"shares_owned_after_display":"50,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-20","scope":"insider"},{"id":8073114,"accession":"0001179110-15-009156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-009156","line_url":"/filing/0001179110-15-009156#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2438.0,"shares_display":"2,438","price_per_share":16.85,"price_display":"16.85","price_state":"stated","total_value":41080.3,"total_display":"41,080.30","total_whole":"41,080","shares_owned_after":33182.0,"shares_owned_after_display":"33,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-04","scope":"insider"},{"id":8224411,"accession":"0001209191-15-046804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-046804","line_url":"/filing/0001209191-15-046804#line-2","is_derivative":false,"issuer_cik":"0001324991","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001324991","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12703.0,"shares_display":"12,703","price_per_share":7.4465,"price_display":"7.45","price_state":"stated","total_value":94592.8895,"total_display":"94,592.89","total_whole":"94,593","shares_owned_after":14324.0,"shares_owned_after_display":"14,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-22","filed_date":"2015-05-26","scope":"insider"},{"id":5696929,"accession":"0001104659-09-013946","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-09-013946","line_url":"/filing/0001104659-09-013946","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10454.0,"shares_display":"10,454","price_per_share":47.681119188827246,"price_display":"47.68","price_state":"stated","total_value":498458.42,"total_display":"498,458.42","total_whole":"498,458","shares_owned_after":137076.0,"shares_owned_after_display":"137,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-27","filed_date":"2009-03-03","scope":"insider","n_lines":9},{"id":5911455,"accession":"0001104659-09-010665","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-09-010665","line_url":"/filing/0001104659-09-010665","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5565.0,"shares_display":"5,565","price_per_share":54.093461994609164,"price_display":"54.09","price_state":"stated","total_value":301030.116,"total_display":"301,030.12","total_whole":"301,030","shares_owned_after":103643.0,"shares_owned_after_display":"103,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-19","scope":"insider","n_lines":2},{"id":9223089,"accession":"0001104659-09-010511","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001104659-09-010511","line_url":"/filing/0001104659-09-010511","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33642.0,"shares_display":"33,642","price_per_share":55.25540812080138,"price_display":"55.26","price_state":"stated","total_value":1858902.44,"total_display":"1,858,902.44","total_whole":"1,858,902","shares_owned_after":20445.0,"shares_owned_after_display":"20,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-18","scope":"insider","n_lines":15},{"id":5871972,"accession":"0001104659-09-006508","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001104659-09-006508","line_url":"/filing/0001104659-09-006508#line-19","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55333.0,"shares_display":"55,333","price_per_share":54.7391,"price_display":"54.74","price_state":"stated","total_value":3028878.6203,"total_display":"3,028,878.62","total_whole":"3,028,879","shares_owned_after":57143.0,"shares_owned_after_display":"57,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5871970,"accession":"0001104659-09-006508","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001104659-09-006508","line_url":"/filing/0001104659-09-006508#line-18","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":55.33,"price_display":"55.33","price_state":"stated","total_value":293249.0,"total_display":"293,249.00","total_whole":"293,249","shares_owned_after":15145.0,"shares_owned_after_display":"15,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5871968,"accession":"0001104659-09-006508","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001104659-09-006508","line_url":"/filing/0001104659-09-006508#line-17","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001324991","owner_name":"Tyree James L","owner_display_name":"Tyree James L","owner_url":"/insider/0001324991","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":55.21,"price_display":"55.21","price_state":"stated","total_value":265008.0,"total_display":"265,008.00","total_whole":"265,008","shares_owned_after":40487.0,"shares_owned_after_display":"40,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"}],"collapsed":true,"next_cursor":"2009-02-02|5871968","ledger_fault":false,"count":{"value":115,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":114,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":115},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001231457","name":"GENELUX Corp","url":"/issuer/0001231457","role":"Director","n_filings":4,"first_seen":"2023-12-14","last_seen":"2024-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001808665","name":"Assertio Holdings, Inc.","url":"/issuer/0001808665","role":"Director","n_filings":3,"first_seen":"2022-05-16","last_seen":"2024-03-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001340652","name":"ChemoCentryx, Inc.","url":"/issuer/0001340652","role":"Director","n_filings":7,"first_seen":"2015-05-26","last_seen":"2022-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"Innoviva, Inc.","url":"/issuer/0001080014","role":"Director","n_filings":2,"first_seen":"2015-06-04","last_seen":"2016-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (Executive Vice President)","n_filings":13,"first_seen":"2006-02-22","last_seen":"2009-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001324991","retrieved_at":"2026-08-23T17:39:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}